In summary, our work highlights RNF8 downregulation as a strategy exploited by GSC to prevent mitotic checkpoint, and more importantly, a previously unrecognized CAMK2D-RNF8-MAD2 complex that can generate mitotic checkpoint signal in glioma. This evidence concerns the gene MAD2L1 and central nervous system cancer.